Savara Inc. is a biotech company focused on rare lung diseases that joined the Nasdaq in 2017. Today, management shared the news that lead candidate, molgramostim met primary and secondary endpoints ...
While RNA-medicine developer Wave Life Sciences Ltd. brought in a clinical data win, it also got knocked back a step as a major collaborator will go its separate way. That didn’t stop Wave’s stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results